SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,629.34 313.73
( 0.42%)

Global Indices

Nasdaq

52,191.76 549.28
(1.06%)

Dow Jones

7,764.37 24.43
(0.32%)

Hang Seng

64,657.00 -3,087.29
(-4.56%)

Nikkei 225

10,840.19 115.33
(1.08%)

Forex

USD-INR

95.08 -0.14
(-0.15%)

EUR-INR

106.23 -0.27
(-0.26%)

GBP-INR

125.74 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

132.68

422426.91

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.91

Back

croissance limited

Foseco India consolidated net profit rises 56.02% in the March 2026 quarter

May 13,2026

Net profit of Foseco India rose 56.02% to Rs 33.81 crore in the quarter ended March 2026 as against Rs 21.67 crore during the previous quarter ended March 2025. Sales rose 35.94% to Rs 201.88 crore in the quarter ended March 2026 as against Rs 148.51 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	201.88	148.51	36
OPM %	20.48	18.38	-
PBDT	49.58	31.48	57
PBT	41.43	29.14	42
NP	33.81	21.67	56

74,629.34 313.73 ( 0.42%)

52,191.76 549.28 (1.06%)

7,764.37 24.43 (0.32%)

64,657.00 -3,087.29 (-4.56%)

10,840.19 115.33 (1.08%)

95.08 -0.14 (-0.15%)

106.23 -0.27 (-0.26%)

125.74 -0.30 (-0.24%)

0.60 0.00 (-0.23%)